- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 40/31 - Récepteurs antigéniques chimériques [CAR]
Détention brevets de la classe A61K 40/31
Brevets de cette classe: 1833
Historique des publications depuis 10 ans
|
0
|
1
|
5
|
23
|
81
|
94
|
54
|
40
|
759
|
169
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4392 |
64 |
| The Regents of the University of California | 20427 |
45 |
| Kite Pharma, Inc. | 427 |
39 |
| Memorial Sloan-Kettering Cancer Center | 1997 |
34 |
| City of Hope | 1013 |
33 |
| Board of Regents, The University of Texas System | 6020 |
31 |
| Juno Therapeutics, Inc. | 487 |
31 |
| Janssen Biotech, Inc. | 1639 |
29 |
| The Board of Trustees of the Leland Stanford Junior University | 6589 |
26 |
| Novartis AG | 10462 |
25 |
| Autolus Limited | 264 |
23 |
| Allogene Therapeutics, Inc. | 156 |
23 |
| Immunitybio, Inc. | 487 |
19 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1003 |
18 |
| Sloan-Kettering Institute for Cancer Research | 569 |
18 |
| Memorial Hospital for Cancer and Allied Diseases | 351 |
18 |
| The General Hospital Corporation | 4802 |
17 |
| Dana-Farber Cancer Institute, Inc. | 2640 |
17 |
| Regeneron Pharmaceuticals, Inc. | 4541 |
17 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2952 |
16 |
| Autres propriétaires | 1290 |